ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Ohio » Medical Oncology

Top Medical Oncology Prescribers in Ohio

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KHAWAJA HAMID M.D.

Medical Oncology

1,850

$824K

253
195 are 65+

21%
patients receiving schedule two controlled substances

Avg: 27%

9%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 21%

$446
Average prescription price

Avg: $506

SUSHIL JAIN MD

Medical Oncology

1,642

$84K

169
137 are 65+

11%
patients receiving schedule two controlled substances

Avg: 27%

10%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 21%

$51
Average prescription price

Avg: $506

JOSE BARREAU M.D.

Medical Oncology

1,531

$442K

272
213 are 65+

12%
patients receiving schedule two controlled substances

Avg: 27%

7%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 21%

$289
Average prescription price

Avg: $506

JAMES MAHER M.D.

Medical Oncology

1,484

$583K

231
199 are 65+

12%
patients receiving schedule two controlled substances

Avg: 27%

12%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 21%

$393
Average prescription price

Avg: $506

THOMAS SWEENEY M.D.

Medical Oncology

1,435

$336K

251
226 are 65+

12%
patients receiving schedule two controlled substances

Avg: 27%

9%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 21%

$234
Average prescription price

Avg: $506

RANGA BRAHMAMDAM M.D.

Medical Oncology

1,405

$838K

171
115 are 65+

33%
patients receiving schedule two controlled substances

Avg: 27%

13%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 21%

$597
Average prescription price

Avg: $506

SCOTT WEGNER MD

Medical Oncology

1,285

$664K

165
134 are 65+

36%
patients receiving schedule two controlled substances

Avg: 27%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 21%

$517
Average prescription price

Avg: $506

APURVA MEHTA MD

Medical Oncology

1,278

$354K

171
135 are 65+

28%
patients receiving schedule two controlled substances

Avg: 27%

14%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 21%

$277
Average prescription price

Avg: $506

GARY SCHNUR MD

Medical Oncology

1,191

$348K

192
170 are 65+

6%
patients receiving schedule two controlled substances

Avg: 27%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 21%

$292
Average prescription price

Avg: $506

KATHRYN FACCINI MD

Medical Oncology

1,139

$258K

151
135 are 65+

9%
patients receiving schedule two controlled substances

Avg: 27%

9%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 21%

$227
Average prescription price

Avg: $506

WILLIAM HICKS M.D.

Medical Oncology

1,133

$672K

111
88 are 65+

15%
patients receiving schedule two controlled substances

Avg: 27%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 21%

$593
Average prescription price

Avg: $506

DAVID KIRLIN MD

Medical Oncology

1,074

$522K

190
165 are 65+

17%
patients receiving schedule two controlled substances

Avg: 27%

13%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 21%

$486
Average prescription price

Avg: $506

ADNAN ALKHALILI MD

Medical Oncology

1,022

$134K

170
115 are 65+

31%
patients receiving schedule two controlled substances

Avg: 27%

24%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 21%

$131
Average prescription price

Avg: $506

FREDERIC REU M.D.

Medical Oncology

1,009

$1.25M

86
67 are 65+

28%
patients receiving schedule two controlled substances

Avg: 27%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 21%

$1239
Average prescription price

Avg: $506

JEANNA KNOBLE MD

Medical Oncology

947

$414K

185
154 are 65+

26%
patients receiving schedule two controlled substances

Avg: 27%

14%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 21%

$437
Average prescription price

Avg: $506

JOSEPH KOENIG M.D.

Medical Oncology

932

$500K

164
135 are 65+

23%
patients receiving schedule two controlled substances

Avg: 27%

10%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 21%

$536
Average prescription price

Avg: $506

SALVATORE VELTRI M.D.

Medical Oncology

803

$608K

97
78 are 65+

14%
patients receiving schedule two controlled substances

Avg: 27%

12%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 21%

$758
Average prescription price

Avg: $506

ROBERT DEAN MD

Medical Oncology

757

$617K

59
35 are 65+

29%
patients receiving schedule two controlled substances

Avg: 27%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 21%

$816
Average prescription price

Avg: $506

SUSAN LEGRAND MD

Medical Oncology

751

$131K

67
41 are 65+

63%
patients receiving schedule two controlled substances

Avg: 27%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 21%

$175
Average prescription price

Avg: $506

G THOMAS BUDD MD

Medical Oncology

714

$527K

127
94 are 65+

20%
patients receiving schedule two controlled substances

Avg: 27%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 21%

$739
Average prescription price

Avg: $506

R TROCHELMAN M.D.

Medical Oncology

711

$659K

116
101 are 65+

25%
patients receiving schedule two controlled substances

Avg: 27%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 21%

$928
Average prescription price

Avg: $506

MAHMOUD CHARIF MD

Medical Oncology

667

$97.2K

115
61 are 65+

33%
patients receiving schedule two controlled substances

Avg: 27%

10%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 21%

$146
Average prescription price

Avg: $506

HOLLY DUSHKIN M.D.

Medical Oncology

660

$170K

110
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 27%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 21%

$257
Average prescription price

Avg: $506

MANISHA SHAH M.D.

Medical Oncology

656

$590K

90
54 are 65+

38%
patients receiving schedule two controlled substances

Avg: 27%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 21%

$899
Average prescription price

Avg: $506

REBECCA BECHHOLD MD

Medical Oncology

602

$57.2K

104
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 27%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

9%
prescriptions for brand name drugs

Avg: 21%

$95
Average prescription price

Avg: $506

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank